259 related articles for article (PubMed ID: 26297987)
1. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
[TBL] [Abstract][Full Text] [Related]
2. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways.
Ma W; Na M; Tang C; Wang H; Lin Z
Mol Med Rep; 2015 Jul; 12(1):1050-8. PubMed ID: 25777142
[TBL] [Abstract][Full Text] [Related]
4. N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1α by human gastric cancer cells.
Murakami Y; Watari K; Shibata T; Uba M; Ureshino H; Kawahara A; Abe H; Izumi H; Mukaida N; Kuwano M; Ono M
J Biol Chem; 2013 Aug; 288(35):25025-25037. PubMed ID: 23846687
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis.
Parmaksız G; Czabanka M; Vinci M; Vajkoczy P
J Vasc Res; 2014; 51(2):102-9. PubMed ID: 24556643
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
9. EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway.
Bonavia R; Inda MM; Vandenberg S; Cheng SY; Nagane M; Hadwiger P; Tan P; Sah DW; Cavenee WK; Furnari FB
Oncogene; 2012 Sep; 31(36):4054-66. PubMed ID: 22139077
[TBL] [Abstract][Full Text] [Related]
10. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
11. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.
Hueng DY; Lin GJ; Huang SH; Liu LW; Ju DT; Chen YW; Sytwu HK; Chang C; Huang SM; Yeh YS; Lee HM; Ma HI
J Neurooncol; 2011 Aug; 104(1):21-31. PubMed ID: 21116837
[TBL] [Abstract][Full Text] [Related]
13. Activation of alternate prosurvival pathways accounts for acquired sunitinib resistance in U87MG glioma xenografts.
Zhou Q; Lv H; Mazloom AR; Xu H; Ma'ayan A; Gallo JM
J Pharmacol Exp Ther; 2012 Nov; 343(2):509-19. PubMed ID: 22869928
[TBL] [Abstract][Full Text] [Related]
14. EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.
Uhl C; Markel M; Broggini T; Nieminen M; Kremenetskaia I; Vajkoczy P; Czabanka M
Angiogenesis; 2018 Nov; 21(4):873-881. PubMed ID: 29987450
[TBL] [Abstract][Full Text] [Related]
15. mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy.
Weiler M; Blaes J; Pusch S; Sahm F; Czabanka M; Luger S; Bunse L; Solecki G; Eichwald V; Jugold M; Hodecker S; Osswald M; Meisner C; Hielscher T; Rübmann P; Pfenning PN; Ronellenfitsch M; Kempf T; Schnölzer M; Abdollahi A; Lang F; Bendszus M; von Deimling A; Winkler F; Weller M; Vajkoczy P; Platten M; Wick W
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):409-14. PubMed ID: 24367102
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin increases migration and angiogenesis in malignant glioma.
Grau SJ; Trillsch F; Tonn JC; Goldbrunner RH; Noessner E; Nelson PJ; von Luettichau I
Int J Clin Exp Pathol; 2015; 8(7):8663-70. PubMed ID: 26339454
[TBL] [Abstract][Full Text] [Related]
19. NF-κB-related decrease of glioma angiogenic potential by graphite nanoparticles and graphene oxide nanoplatelets.
Wierzbicki M; Sawosz E; Strojny B; Jaworski S; Grodzik M; Chwalibog A
Sci Rep; 2018 Oct; 8(1):14733. PubMed ID: 30283098
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
